In vivo microdialysis to determine the relative pharmacokinetics of drugs

Biological and Pharmaceutical Bulletin

Volumn 19, Issue 7, 1996, Pages 988-994

  Nakashima, Mikiro ^a   Zhao, Mei Feng ^a   Nakashima, Mihoko N ^a   Sakurai, Masaharu ^a   Sasaki, Hitoshi ^a   Matsuyama, Kenji ^a   Ichikawa, Masataka ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

blood microdialysis; brain microdialysis; drug interaction; inhibitor; L 3,4 dihydroxyphenylalanine (L dopa); pharmacokinetics

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; AROMATIC LEVO AMINO ACID DECARBOXYLASE; BENSERAZIDE; CARBIDOPA; HOMOVANILLIC ACID; LEVODOPA;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG INHIBITION; DRUG METABOLISM; DRUG TRANSPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MICRODIALYSIS; NONHUMAN; RAT;

EID: 9344234442     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.19.988     Document Type: Article

References (26)

1. Cedarbaum J. M., Schleiler L. S., "Goodman and Gilman's the Pharmacological Basis of Therapeutics," 8th ed., ed. by Gilman A. G., Rail T. W., Nies A. S., Taylor P., Pergamon Press, New York, 1990, pp. 463-484.
2. Cedarbaum J. M., Clin. Pharmacokinet., 13, 141-178 (1987).
3. Saisho Y., Umeda T., Chem. Pharm. Bull., 39, 808-810 (1991).
4. Scott D. O., Sorenson L. R., Steele K. L., Puckett C. E., Lunte C. E., Pharm. Res., 8, 389-392 (1991).
5. Telting-Diaz M., Scott D. O., Lunte C. E., Anal. Chem., 64, 806-810 (1992).
6. Quellec A. L., Dupin S., Tufenkji A. E., Genissel P., Houin G., Pharm. Res., 11, 835-838 (1994).
7. Nakashima M., Takeuchi N., Hamada M., Matsuyama K., Ichikawa M., Goto S., Biol. Pharm. Bull. 17, 1630-1634 (1994).
8. Sarre S., Deleu D., Van Belle K., Ebinger G., Michotte Y., Pharm. Res., 12, 746-750 (1995).
9. Stenken J. A., Topp E. M., Southard M. Z., Lunte C. E., Anal. Chem., 65, 2324-2328 (1993).
10. Wolf J. H., Veenma-van Der Duin L., Korf J., J. Pharm. Pharmacol., 43, 101-106 (1990).
11. Lunte C. E., Scott D. O., Kissinger P. T., Anal. Chem., 63, 773A-780A (1992).
12. Deguchi Y., Terasaki T., Yamada H., Tsuji A., J. Pharmacobio-Dyn., 15, 79-89 (1992).
13. Yokel R. A., Allen D. D., Burgio D. E., McNamara P. J., J. Pharmacol. Toxicol. Meth., 27, 135-142 (1992).
14. Wang Y., Wong S. L., Sawchuk R. J., Pharm. Res., 10, 1411-1419 (1993).
15. Wong S. L., Van Belle K., Sawchuk R. J., J. Pharmacol. Exp. Ther., 264, 899-909 (1993).
16. Ault J. M., Riley C. M., Meltzer N. M., Lunte C. E., Pharm. Res., 11, 1631-1639 (1994).
17. Benveniste H., Hansen A. J., Ottosen N. S., J. Neurochem., 52, 1741-1750 (1989).
18. Bungay P. M., Morrison P. F., Dedrick R. L., Life Sci.. 46, 105-119 (1990).
19. Morrison P. F., Bungay P. M., Hsiao J. K., Ball B. A., Mefford I. N., Dedrick R. L., J. Neurochem., 57, 103-119 (1991).
20. Paxinos G., Watson C, "The Rat Brain in Stereotaxic Coordinates," 2nd ed., Academic Press, San Diego, 1986.
21. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T., J. Pharmacobio-Dyn., 4, 879-885 (1981).
22. Ehrenstrom F., Johansson P., Life Sei., 36, 867-879 (1985).
23. Nutt J. G., Fellman J. H., Clin. Neuropharmacol., 7, 35-49 (1984).
24. Mannisto P. T., Kaakkola S., Pharmacol. Toxicol., 66, 317-323 (1990).
25. Rose S., Jenner P., Marsden C. D., J. Pharm. Pharmacol., 43, 325-330 (1991).
26. Acquas E., Carboni E., De Ree R. H. A., Da Prada M., Di Chiara G., J. Neurochem., 59, 326-330 (1992).